您当前的位置:检测资讯 > 法规标准

FDA:药企质量部门最为重要的十项工作

嘉峪检测网        2023-10-07 09:02

The pharmaceutical Quality Unit has beenthe target of many FDA Warning Letters as the underlying cause of productquality and CGMP compliance problems. We have seen instances where the ultimate“no confidence” vote is cast when third-party experts are either recommended byFDA, or court ordered to take over their duties.
 
药品质量部门一直是许多FDA警告信中产品质量和CGMP合规问题的目标。我们已经看到,当FDA或法院命令推荐第三方专家时,最终投了"不信任"票。
 
Therefore, it’svery important to have a clear understanding of the regulatory responsibilitiesof the Quality Unit and to ensure that those responsibilities are effectivelyexecuted.
 
因此,必须清楚地了解质量部门的监管职责,并确保这些职责得到有效执行。
 
Remember—theQuality Unit is the only job description that appears in the Code of FederalRegulations!
 
请记住,质量部门是联邦法规中唯一有所描述的工作!
 
Here defines thejob of the Quality Unit.
 
以下描述质量部门的工作。
 
1. To establish the quality system
 
建立质量体系
 
Establish the quality management system to describe     how the firm follows CGMPs and operates to maintain a state of control
 
建立质量管理体系,描述公司如何遵循 CGMP 并运营以保持控制状态
 
Keep the quality management system current with good     industry practices
 
通过良好的行业实践保持质量管理体系与时俱进
 
2. To audit compliance to the qualitysystem
 
审查质量体系的遵守情况
 
Audit for compliance to policies and procedures: on     paper vs. practice.
 
对政策和程序的遵守情况进行审查:书面审查或实际审查。
 
Report quality system performance metrics, including     trends, that help decision-making and taking proactive targeted actions
 
报告质量体系性能指标(包括趋势),帮助决策并采取主动有针对性的措施
 
3. To establish procedures andspecifications
 
制定程序和标准
 
Ensure that procedures and specifications are     appropriate and followed
 
确保程序和标准适当并得到遵循
 
Ensure that the procedures and specifications of     firms under contract are also appropriate and followed, i.e., maintain     control and take responsibility for third-party services providers     (contract manufacturers, contract laboratories, etc.)
 
确保合同公司的程序和标准同样适当并得到遵循,例如保持控制并对第三方提供商(合同制造商、合同实验室等)负责
 
4. To establish manufacturing controls
 
建立生产控制
 
Ensure that appropriate manufacturing in-process     controls are implemented
 
确保实施适当的生产过程控制
 
Ensure in-process controls are performed during     manufacturing operations and results are satisfactory
 
确保在生产操作期间执行过程控制,并确保结果令人满意
 
5. To perform laboratory tests orexaminations
 
确保实验室测试或检查
 
Perform laboratory testing of components,     containers, in-process materials, packaging materials and drug product     using validated methods against scientifically-derived,     fit-for-purpose specifications
 
确保使用基于科学的与其标准相适应的经验证的方法对组分、容器、中间产品、包装材料和成品进行实验室测试
 
Approve or reject drug products manufactured,     processed, packed, or held under contract by another company, i.e., final     product release is not delegated to a contractor.
 
批准或拒绝合同制造组织生产、加工、包装或保存的药品,即最终产品放行不委托给受托方。
 
Perform retests or reexamine approved components,     drug product containers and closures after long storage or exposure to     adverse conditions
 
对已批准的组分、药品容器和密封部件经长期存放或暴露于不利条件后,执行复检或复验。
 
6. To review and approve or reject allthings CGMP
 
审核、批准或拒绝 CGMP 范围内的所有内容
 
Review and approve/reject any document that gives     work instructions and set requirements such as procedures, protocols, test     methods, and specifications—including changes to these documents
 
审核和批准/拒绝任何包含工作说明和设置要求的文件,如程序、方案、检验方法和标准,包括对这些文件的更改
 
Review and approve/reject reprocessing and rework     procedures
 
审核和批准/拒绝重新加工和返工程序
 
Review and approve/reject production batch records     and make the final decision to release a product lot into commerce.
 
审核和批准/拒绝生产批记录,并最终决定批产品是否可以销售。
 
7. To ensure investigation ofnonconformance
 
确保对不合格的调查
 
Ensure investigation is conducted and root cause is     eliminated for production and control record errors, discrepancies, and     failure to meet specification, including quality attributes
 
确保对生产和控制记录的错误、偏差和不合格(包括质量属性)的调查得到实施,并消除根本原因
 
Review complaints to determine if it relates to a     failure to meet specification, if so investigate and report to FDA if it     is serious and unexpected
 
审查投诉,以确定它是否与不合格有关,如果是,进行调查。如是严重和意外的,向药监局报告
 
8. To keep management informed
 
随时通知管理层
 
Report on product, process and system risks—and keep     management informed
 
报告产品、工艺和系统风险,并随时向管理层通报
 
Report on outcome of regulatory inspections and     ensure responses are complete and managed to verifiable closure—and keep     management informed.
 
报告监管检查的结果,并确保答复完整并管理以使关闭可确认,并随时向管理层通报。
 
Keep management informed—get it?
 
随时向管理层通报—重要的事情说三遍
 
9. To describe responsibilities in writing
 
以书面形式描述责任
 
Have a complete and compliant procedure that     describes responsibilities
 
建立完整且合规的程序,描述职责
 
Follow the procedure
 
遵循规程
 
10. To remainindependent
 
保持独立
 
Ensure there is no conflict of interest between     regulatory responsibilities and actual daily activities
 
确保监管责任与实际日常活动之间没有利益冲突
 
Be independent reviewer and approver with respect to     manufacturing and process/ product development units
 
在生产和工艺/产品开发方面作为独立的审核者和批准者
 
Don’t drink the “Kool-Aid”
 
切勿偏听偏信
 

 
分享到:

来源:GMP办公室